Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 13Colorectal Neoplasms 6Neoplasms 4Thyroid Neoplasms 3Prostatic Neoplasms 3Ovarian Neoplasms 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Unmet Fertility Information Needs 1Thyroid Cancer, Papillary 1Smoking Cessation 1Patient Participation 1Papillary Thyroid Microcarcinoma 1Neuroma, Acoustic 1Melanoma 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Healthy Volunteers 1Depression 1Dementia 1Colorectal Cancer Screening 1Carcinoma, Renal Cell 1Carcinoma, Medullary 1Carcinoma, Intraductal, Noninfiltrating 1COVID-19 1Breast Carcinoma In Situ 1Behavior 1Advanced Cancer 1

Interventions

Nivolumab 143pembrolizumab 129Sunitinib 127Bevacizumab 71Everolimus 70Sorafenib 68cabozantinib 64Ipilimumab 61pazopanib 58Axitinib 57aldesleukin 51Magnetic Resonance Spectroscopy 43Cyclophosphamide 40Interleukin-2 38lenvatinib 36Radiosurgery 36Specimen Handling 33Interferon-alpha 32atezolizumab 29belzutifan 24temsirolimus 23Gemcitabine 23fludarabine phosphate 22Radiotherapy 18Interferon alpha-2 18Biopsy 18fludarabine 17durvalumab 17avelumab 17Paclitaxel 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Renal Cell × Decision Support Techniques × Clear all
NCT05387863 2025-12-02

Decision Aid (DA) for Renal Patients

NYU Langone Health

Phase NA Recruiting
40 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡